Clinical Trials Browser

Terminated × Lymphoma, Non-Hodgkin × Colony-Stimulating Factors × Clear all

NCT00481832 2018-02-14

Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma

Phase 2 Terminated

50 enrolled 18 charts

Lymphoma, Non-Hodgkin